Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Employee survey — Pride & connection to purpose by Year
Employee survey — Pride & connection to purpose (%) (%)
Pfizer Employee survey — Pride & connection to purpose: 86.0% in FY2025, up 1.0 pts from a year earlier.
Latest, FY2025
86.0%
Period ended Dec 31, 2025
Change on a year earlier
+1.0 pts
85.0% in FY2024
History
3 years
Since FY2023
Sources
1
Pfizer Official Report — Pfizer 2025 Impact Report 02JUN2026
Where the FY2025 figure comes from
“and PAXLOVID®) and PAXLOVID®) and PAXLOVID®) Employee Purpose 89% 85% 86%”
Source: Pfizer Official Report — Pfizer 2025 Impact Report 02JUN2026 ↗
Reported in Pfizer Annual Impact / ESG Report.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Employee survey — Pride & connection to purpose (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 86.0% | +1.0 pts | Pfizer Official Report — Pfizer 2025 Impact Report 02JUN2026 ↗ |
| FY2024 | Dec 31, 2024 | 85.0% | -4.0 pts | Pfizer Official Report — Pfizer 2025 Impact Report 02JUN2026 ↗ |
| FY2023 | Dec 31, 2023 | 89.0% | – | Pfizer Official Report — Pfizer 2025 Impact Report 02JUN2026 ↗ |
Cite this data
StockData. (2026). Pfizer Employee survey — Pride & connection to purpose (%), annual FY2023–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/esg-emp-purpose
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.